Stocks and InvestingStocks and Investing
Fri, August 19, 2022
Thu, August 18, 2022
Wed, August 17, 2022

David Westenberg Maintained (AKYA) at Buy with Increased Target to $17 on, Aug 17th, 2022


Published on 2024-10-27 22:42:39 - WOPRAI, David Westenberg
  Print publication without navigation


David Westenberg of Piper Sandler, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Increased Target from $14 to $17 on, Aug 17th, 2022.

David has made no other calls on AKYA in the last 4 months.



There are 2 other peers that have a rating on AKYA. Out of the 2 peers that are also analyzing AKYA, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Mark Massaro of "BTIG" Initiated at Strong Buy and Held Target at $16 on, Wednesday, June 22nd, 2022
  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $18 on, Monday, May 9th, 2022